The Exercise Evidence, Part 4: Did the Famous Brain-Growth Finding Hold Up?
The famous 2011 finding that walking grew the hippocampus faced the test every result must pass: could another team reproduce it? Across the replication decade, the larger and longer trials cut it down to its honest size. Exercise did not rebuild the aging brain, but it slowed what age takes.
For a few years, exercise science had its perfect headline. A 2011 trial reported that a single year of walking had reversed the slow shrinkage of the hippocampus, the brain's memory center, enlarging it by about 2 percent in healthy older adults. It was the result the whole field had been waiting for, and Part 3 ended right there at the peak, with the finding in print and a quiet rebuttal already sitting beside it. This post is about what happened next, when other teams set out to do the one thing that turns a striking result into a fact, which is repeat it.
Until now the story has moved in a straight line, with each study answering the one before it. After 2011 that line splits, because resistance training, the large multidomain prevention programs, the question of whether exercise touches the disease itself, and the question of whether any of it was ever cause rather than coincidence all begin moving at once, on separate tracks, across the same decade. So from here I am going to take them one at a time, and this post stays on the track the famous 2011 result opened, which is the simplest version of the question, whether exercise actually changes the structure of the aging brain.
There was every reason to think it would, because the animal work was clean. Mice given a running wheel grew new neurons in the hippocampus and learned faster, and the effect held even in old animals. If running could build hippocampal tissue in a mouse, then a 2 percent gain in an older human looked like the same biology showing up where it counted. The expectation was reasonable, and what followed was more complicated.
The most thorough check came in 2018, when a group pooled every controlled trial that had put exercisers in a scanner and measured the hippocampus. It came to fourteen trials and 737 people. If the 2011 result reflected something general about exercise and the brain, it should have held up once all of that was stacked together, and it did not. Across the full set of studies there was no significant effect on total hippocampal volume. The headline number from seven years earlier simply did not reappear once the field added up everything it had.
Something smaller did survive, and it is worth being precise about what. On the left side of the hippocampus there was a modest positive effect, and among the healthy older adults in the analysis, both sides showed one. But when the authors looked inside the exercise groups at the raw change, the volume had not actually grown. The entire effect came from the fact that the control groups lost volume over time while the exercisers lost less. Exercise was not building the hippocampus, it was slowing the rate at which the hippocampus was shrinking. That is a real result, and a far more modest one than the word increase had implied. It also rested on uneven ground, since only three of the fourteen trials met the highest standard for avoiding bias, and the authors noted that a bigger hippocampus did not reliably go with sharper thinking. In one trial the structural gain even came alongside worse cognitive scores.
So the famous result did not fall apart so much as shrink to its honest size. The brain-building story had become a brain-preserving story, small, one-sided, and uncertain in what it meant for memory.
The other major test of the decade came from Norway, and it was built on a scale almost no one attempts. The Generation 100 study randomized 1,567 adults aged 70 to 77 to one of three paths for five full years, either two sessions a week of high-intensity interval training, two sessions a week of moderate continuous training, or a control condition that simply asked people to follow the national activity guidelines. Five years is an enormous commitment for a trial like this, far longer than the single year behind the 2011 result, and the training was supervised, so it genuinely happened.
Its main question was survival, and on that the answer was flat. Death from any cause did not differ between the combined exercise group and the control group, with a hazard ratio of 0.92 and a confidence interval running from 0.58 to 1.47. The reason behind the null matters as much as the null itself, because the control group was never sedentary. They had been asked to follow the national guidelines and they did, with many of them taking up high-intensity training on their own, so their exercise dose ended up sitting between the two supervised programs. The groups did not even differ significantly in how much their peak oxygen uptake, the standard measure of cardiorespiratory fitness, changed over the five years.
Cognition came in a separate paper, drawn from 945 of the participants who took the Montreal Cognitive Assessment at the end. In this group the controls were strikingly active, with 96 percent meeting the national guidelines by year five, which is the backdrop for everything that follows. Being assigned to exercise made no real difference. The exercisers did not score meaningfully better than the controls, and their odds of mild cognitive impairment were no different. When the data were split by sex, the men who exercised scored modestly higher and had lower odds of impairment than the men in the control group, while the women showed nothing, a split the authors themselves called underpowered and unusual, since most studies that find a sex difference find it the other way.
That same paper turned the question around, and this is the part worth slowing down on. Instead of sorting people by the program they were assigned to, it sorted them by what actually happened to their fitness over the five years, and looked at that way, fitness and cognition rose and fell together. Across the whole group, each one-MET gain in VO2peak came with about half a point more on the cognitive test, 0.46 to be exact, and roughly 27 percent lower odds of mild cognitive impairment. But the moment the participants were split into those who lost fitness, held steady, or gained it, the signal turned out to come almost entirely from decline. The people whose fitness fell scored worse than those who held steady, while the 57 whose fitness rose gained nothing the study could confirm. So the honest version is a narrow one. Losing fitness tracked with losing ground, and gaining it, here, bought nothing you could point to.
Put the whole decade together and it reads as a correction rather than a collapse. The 2011 finding was not fabricated, and the biology under it is real. The larger and longer trials simply cut it down to its honest size. Exercise was not rebuilding the aging brain, and at its best it was slowing what age takes away. Added on top of a life that was already active, it left cognition about where it found it.
But the story did not end there. The clearest evidence that exercise can protect the brain, the one place where thinking and brain structure moved together, came from people who had already begun to slip. That is where Part 5 begins.
References
- van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci USA. 1999;96(23):13427-13431. https://doi.org/10.1073/pnas.96.23.13427
- Firth J, Stubbs B, Vancampfort D, et al. Effect of aerobic exercise on hippocampal volume in humans: a systematic review and meta-analysis. NeuroImage. 2018;166:230-238. https://doi.org/10.1016/j.neuroimage.2017.11.007
- Stensvold D, Viken H, Steinshamn SL, et al. Effect of exercise training for five years on all cause mortality in older adults: the Generation 100 study: randomised controlled trial. BMJ. 2020;371:m3485. https://doi.org/10.1136/bmj.m3485
- Zotcheva E, Håberg AK, Wisløff U, et al. Effects of 5 years aerobic exercise on cognition in older adults: the Generation 100 study: a randomized controlled trial. Sports Med. 2022;52(7):1689-1699. https://doi.org/10.1007/s40279-021-01608-5